NASDAQ: NRXPNrx Pharmaceuticals Inc Stock Ownership - Who owns Nrx Pharmaceuticals?
Insider buying vs selling
Have Nrx Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when NRXP insiders and whales buy or sell their stock.
NRXP Shareholders
What type of owners hold Nrx Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jonathan C. Javitt | 241.74% | 29,236,658 | $34.79M | Insider |
| Daniel C. Javitt | 195.19% | 23,606,657 | $28.09M | Insider |
| Chaim Hurvitz | 20.04% | 2,423,236 | $2.88M | Insider |
| Brac Lending Group LLC | 18.43% | 2,228,435 | $2.65M | Insider |
| Polar Asset Management Partners Inc | 8.31% | 1,005,536 | $1.20M | Insider |
| Big Rock Partners Sponsor LLC | 4.29% | 519,315 | $617.98k | Insider |
| Patrick John Flynn | 3.34% | 404,291 | $481.11k | Insider |
| Richard Ackerman | 2.25% | 272,500 | $324.28k | Insider |
| Vanguard Group Inc | 1.99% | 240,316 | $285.98k | Institution |
| Anson Funds Management LP | 1.18% | 142,525 | $169.60k | Institution |
NRXP vs Biotech Stocks
Nrx Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.